Skip to main content
ClinicalTrials.govcontrolled

A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenop

ClinicalTrials.gov study NCT01684215. IPD Sharing: YES. Countries: 1. Publications: 3.

ShareScore

36/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
12
Harmonization
12
Access
4
Reuse readiness
0
Engagement
8

Topics